MeSH term
Frequency | Condition_Probility | Female | 12 | 0.0 |
Humans | 38 | 0.0 |
Infant | 2 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Neuropilin-1 | 2 | 3.0 |
Receptor Protein-Tyrosine Kinases/*genetics | 3 | 0.0 |
Receptors, Vascular Endothelial Growth Factor | 9 | 1.0 |
Vascular Endothelial Growth Factor Receptor-3 | 21 | 36.0 |
Adult | 6 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 3 | 0.0 |
Endothelial Growth Factors/genetics/*metabolism | 2 | 2.0 |
Immunohistochemistry | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 6 | 2.0 |
Receptors, Growth Factor/*metabolism | 6 | 5.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Tissue Distribution | 5 | 0.0 |
Vascular Endothelial Growth Factor C | 7 | 9.0 |
Animals | 14 | 0.0 |
Mice | 10 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Oligonucleotide Array Sequence Analysis/*methods | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Comparative Study | 8 | 0.0 |
In Situ Hybridization | 6 | 0.0 |
Survival Analysis | 3 | 0.0 |
Lymphatic System/*embryology | 2 | 66.0 |
Amino Acid Sequence | 15 | 0.0 |
Base Sequence | 10 | 0.0 |
Cell Line | 4 | 0.0 |
Chromosomes, Human, Pair 5/genetics | 2 | 2.0 |
Lod Score | 4 | 0.0 |
Male | 9 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Pedigree | 5 | 0.0 |
Penetrance | 2 | 1.0 |
Phosphorylation | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/chemistry/*genetics/*metabolism | 2 | 25.0 |
Receptors, Cell Surface/chemistry/*genetics/*metabolism | 2 | 22.0 |
Sequence Alignment | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
Vascular Endothelial Growth Factor D | 2 | 12.0 |
Gene Expression | 6 | 0.0 |
Prognosis | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Cattle | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Vascular Endothelial Growth Factor A | 5 | 0.0 |
Vascular Endothelial Growth Factors | 5 | 0.0 |
Genotype | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 5 | 4 | 1.0 |
Genetic Heterogeneity | 2 | 0.0 |
Genetic Markers | 3 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 3 | 0.0 |
Endothelial Growth Factors/*genetics/*metabolism | 2 | 14.0 |
Ligands | 3 | 0.0 |
Receptors, Cell Surface/*metabolism | 4 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Rats | 2 | 0.0 |
Exons | 3 | 0.0 |
Genes, Structural | 2 | 0.0 |
Introns | 2 | 0.0 |
Receptors, Cell Surface/*genetics | 3 | 1.0 |
Cloning, Molecular | 6 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Enzyme Activation | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 2 | 0.0 |
